Loading clinical trials...
Loading clinical trials...
Effects of Isometric Gluteal Activation Plus Movement Retraining vs. Gluteal Activation Alone on the Forward Step-Down Test
The purpose of this study is to determine if an isometric gluteal activation home exercise program (HEP) combined with a movement retraining program utilizing feedback cues produces significant changes in scores on the Forward Step-Down Test (FSDT) in healthy young adults with movement coordination impairments. Aim 1: To determine if an isometric gluteal activation HEP with a movement retraining program with feedback cues produces significant changes on scores FSDT compared to the gluteal activation HEP alone. Aim 2: To determine if an isometric gluteal activation HEP followed with a movement retraining program with feedback cues produces significant changes on category FSDT compared to gluteal activation HEP alone. Aim 3: To determine if an isometric gluteal activation HEP with a movement retraining program with feedback cues produces changes in the peak activation of the gluteus medius (GMed) and gluteus maximus (GMax) during the FSDT compared to the gluteal activation HEP alone. Aim 4: To determine if an isometric gluteal activation HEP with a movement retraining program with feedback cues produces changes in the mean activation of the GMed and GMax during the FSDT compared to the gluteal activation HEP alone. Aim 5: To determine if HEP dose has an effect on the FSDT response, as measured by change in score on the FSDT.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
LSU Health Sciences Center at Shreveport
Shreveport, Louisiana, United States
Start Date
January 7, 2026
Primary Completion Date
April 1, 2026
Completion Date
August 1, 2026
Last Updated
January 16, 2026
38
ACTUAL participants
Control HEP focusing on isometric gluteal activation
OTHER
Experimental HEP focusing on isometric gluteal activation plus a movement retaining program
OTHER
Lead Sponsor
Louisiana State University Health Sciences Center Shreveport
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions